From the news

Recent transaction and litigation

Publications

October / 2017

Representation of Enzymotec in its acquisition by Frutarom

Our firm represented Enzymotec (NASDAQ: ENZY), a nutritional ingredients and medical foods manufacturer, in its acquisition by Frutarom (TASE: FRUT), at a value of 290 million dollars. For more information (Hebrew), click here.

September / 2017

Representation of Playbuzz in a funding round

Our firm represented Playbuzz in a $35 million Series C funding round led by Viola Growth.
For more information, click here.

September / 2017

Representation of Arcturus Therapeutics in a merger with Alcobra

Our firm represented Arcturus Therapeutics, Inc. in an agreement to merge with Alcobra Ltd. (NASDAQ: ADHD). For more information, click here.

September / 2017

Representation of Innoviz Technologies in a funding round

Another successful funding round for an automotive company! Our firm represented Innoviz Technologies, a developer of LiDAR sensors, in a $65 million funding round. For more information, click here.

September / 2017

Representation of the Eilat Municipality

Our firm represented the Municipality of Eilat in a petition to the High Court of Justice regarding the closure of Sde Dov. The HCJ dismissed the petition of certain property owners to cancel the Sde Dov Law, and, as a result, the closure of Sde Dov was postponed until 2019. For more information (Hebrew), click here.

August / 2017

Representation of Oryx Vision in a funding round

Our firm represented Oryx Vision, an autonomous car depth sensor developer, in a $50 million funding round. For more information, click here.

August / 2017

Representation of EMK Capital in the acquisition of Luminati

Our firm represented EMK Capital in the acquisition of Luminati, the enterprise proxy network division of Hola Networks. For more information, click here.